Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels
NCT00330980 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2014-03-20
Summary
Statins are cholesterol-lowering medications that are often prescribed for individuals with high cholesterol and who are at risk for heart disease. Preliminary research has shown that statins may have other effects on the body that are unrelated to the heart. The purpose of this study is to evaluate the impact of statins on mood, mental processes, aggression, and serotonin levels.
Conditions
- Dyslipidemias
Interventions
- DRUG
-
40 mg Pravastatin (Pravachol)
Participants will receive 40 mg of pravastatin for 6 months.
- DRUG
-
20 mg Simvastatin
Participants will receive 20 mg of simvastatin for 6 months.
- DRUG
-
Participants will receive placebo for 6 months.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of California, San Diego
lead OTHER
Principal Investigators
-
Beatrice A. Golomb, MD, PhD · University of California, San Diego
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-04-30
- Primary Completion
- 2004-03-31
- Completion
- 2004-03-31
Countries
- United States
Study Locations
More Related Trials
-
Sertraline and Cognitive Therapy in Depressed Alcoholics
NCT00000458 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression
NCT00781326 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression
NCT00641108 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder
NCT06704594 ·Status: RECRUITING ·Phase: PHASE4
-
A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease
NCT00208117 ·Status: TERMINATED ·Phase: PHASE1
-
Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression
NCT00928980 ·Status: COMPLETED ·Phase: NA
-
Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment
NCT00361062 ·Status: COMPLETED ·Phase: NA
-
Mood Effects of Serotonin Agonists Extended
NCT03934710 ·Status: COMPLETED ·Phase: PHASE1
-
Mood, Serotonin and Social Interaction
NCT02051530 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
NCT00704379 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Nocebo Effect: a Prospective Study of Informed Consent as a Factor in the Prevalence of SSRI's Side Effects
NCT01200615 ·Status: UNKNOWN ·Phase: NA
-
Pharmacogenetics of Antidepressant-Induced Disinhibition
NCT03953014 ·Status: RECRUITING
-
Serotonergic Pharmacotherapy for Agitation of Dementia
NCT00009204 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Mild and Subthreshold Depressive Disorders
NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4
-
The Role of Cytokine-Serotonin Interactions in Post-Stroke Depression
NCT00254020 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Medication and Placebo Response in Major Depression
NCT00229476 ·Status: COMPLETED ·Phase: PHASE4
-
Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis
NCT00004300 ·Status: SUSPENDED ·Phase: PHASE2
-
A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
NCT01607593 ·Status: COMPLETED
-
Treatment of Post-Traumatic Brain Injury (TBI) Depression
NCT00233103 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroid Medication and Antidepressants for Treating Major Depression
NCT00208702 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder
NCT04451187 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients
NCT00018759 ·Status: COMPLETED ·Phase: PHASE4
-
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
NCT05415397 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.
NCT03435744 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning
NCT00611975 ·Status: COMPLETED ·Phase: PHASE4